Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Monash IVF Group Limited (MVF.AX)
AUD0.71
+0.00 (+0.00%)
AU ASX Healthcare Medical - Diagnostics & Research
Address
Pelaco Building 1 3121
Richmond, VIC, AU
Richmond, VIC, AU
CEO
Victoria Atkinson Afracma Fracs Mbbs
Website
monashivfgroup.com.au
IPO
2014-06-26
ISIN AU000000MVF3
Description
Founded in 2014 and headquartered in Richmond, Australia, Monash IVF Group Limited delivers specialized reproductive assistance and women's imaging services. Its operations span Australia and Malaysia, offering a broad spectrum of care. This includes diagnostic obstetric and gynecological ultrasound examinations, a range of fertility treatments, and advanced tertiary-level prenatal diagnostics. The company is also a key provider of in-vitro fertilization (IVF) services.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
AUD0.71
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
718.8K
Beta
0.39
Float Shares
294.79M
Free Float %
75.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -0.70% | -2.74% | +2.16% | -16.47% | -3.40% | -8.39% | -37.72% | -17.44% | -58.24% | -60.11% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.71
DCF (Unlevered)
2.24
+218.3%
DCF (Levered)
2.99
+324.8%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
50% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.45
Distress
Piotroski F-Score
6 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Diagnostics & Research: +7.9%+6.7% Q4'25: +9.7% (vs Q4'23)
-
EPS growth Medical - Diagnostics & Research: +30.8%+481.0% ★ Q4'25: -43.7% (vs Q4'23)
-
FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%+15.4% Q4'25: +2.3% (vs Q4'23)
-
EBIT margin Medical - Diagnostics & Research: +9.6%+16.3% ★ Q4'25: +10.8% (vs Q4'23)
-
ROIC Medical - Diagnostics & Research: +5.2%+7.5% ★ Q4'25: +8.1% (vs Q4'23)
-
Share dilution Medical - Diagnostics & Research: 0.0%+0.3% Q4'25: -0.3% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×3.40× Q4'25: 2.60× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Jun 2014 actual |
Jun 2015 actual |
Jun 2016 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 7 Rev. Ana. 5 EPS Ana. |
Jun 2027 7 Rev. Ana. 5 EPS Ana. |
Jun 2028 7 Rev. Ana. 5 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
114.01M
est: 113.74M (+0.2%)
|
124.96M
est: 123.66M (+1.0%)
|
156.56M
est: 156.93M (-0.2%)
|
155.18M
est: 156.91M (-1.1%)
|
150.64M
est: 142.64M (+5.6%)
|
151.98M
est: 153.40M (-0.9%)
|
145.42M
est: 134.66M (+8.0%)
|
183.61M
est: 175.41M (+4.7%)
|
192.29M
est: 192.60M (-0.2%)
|
213.59M
est: 212.50M (+0.5%)
|
254.96M
est: 252.76M (+0.9%)
|
271.92M
est: 267.45M (+1.7%)
|
267.01M
258.97M – 271.77M
-0.2% YoY
|
276.81M
261.87M – 292.68M
+3.7% YoY
|
286.82M
286.82M – 286.83M
+3.6% YoY
|
| EBITDA |
38.35M
est: 22.01M (+74.2%)
|
40.96M
est: -26.96M (+251.9%)
|
49.61M
est: 33.35M (+48.7%)
|
48.99M
est: 36.55M (+34.0%)
|
38.12M
est: 34.84M (+9.4%)
|
36.45M
est: 27.54M (+32.4%)
|
32.84M
est: 20.70M (+58.7%)
|
51.21M
est: 11.73M (+336.5%)
|
43.16M
est: 12.77M (+238.1%)
|
48.49M
est: 13.31M (+264.2%)
|
10.78M
est: 13.91M (-22.5%)
|
53.01M
est: 51.05M (+3.8%)
|
51.67M
50.12M – 52.59M
+1.2% YoY
|
53.57M
50.68M – 56.64M
+3.7% YoY
|
55.51M
55.51M – 55.51M
+3.6% YoY
|
| EBIT |
35.95M
est: 14.67M (+145.0%)
|
37.90M
est: 23.97M (+58.1%)
|
45.37M
est: 45.17M (+0.4%)
|
44.61M
est: 45.60M (-2.2%)
|
33.16M
est: 41.06M (-19.2%)
|
32.74M
est: 34.66M (-5.5%)
|
20.80M
est: 27.12M (-23.3%)
|
38.65M
est: 24.67M (+56.7%)
|
28.37M
est: 26.84M (+5.7%)
|
33.14M
est: 27.99M (+18.4%)
|
-7.80M
est: 29.25M (-126.7%)
|
44.17M
est: 34.04M (+29.8%)
|
34.45M
33.41M – 35.06M
+1.2% YoY
|
35.71M
33.79M – 37.76M
+3.7% YoY
|
37.01M
37.01M – 37.01M
+3.6% YoY
|
| Net Income |
2.58M
est: 35.99M (-92.8%)
|
21.37M
est: 2.88M (+640.9%)
|
28.78M
est: 27.25M (+5.6%)
|
29.62M
est: 28.92M (+2.4%)
|
21.35M
est: 27.26M (-21.7%)
|
19.85M
est: 22.32M (-11.1%)
|
11.73M
est: 17.21M (-31.8%)
|
25.15M
est: 13.25M (+89.8%)
|
18.41M
est: 14.42M (+27.7%)
|
21.84M
est: 21.84M (+0.0%)
|
-6.53M
est: -6.53M (+0.0%)
|
25.01M
est: 28.28M (-11.6%)
|
18.81M
18.28M – 19.34M
-33.5% YoY
|
19.98M
16.31M – 22.83M
+6.2% YoY
|
22.54M
19.94M – 24.79M
+12.8% YoY
|
| SGA |
8.60M
est: 35.61M (-75.8%)
|
8.76M
est: 67.90M (-87.1%)
|
50.23M
est: 87.69M (-42.7%)
|
52.60M
est: 89.30M (-41.1%)
|
51.92M
est: 82.78M (-37.3%)
|
11.01M
est: 97.31M (-88.7%)
|
54.71M
est: 81.98M (-33.3%)
|
62.15M
est: 102.71M (-39.5%)
|
73.31M
est: 111.77M (-34.4%)
|
81.05M
est: 116.54M (-30.4%)
|
96.54M
est: 121.78M (-20.7%)
|
23.82M
est: 131.70M (-81.9%)
|
83.60M
81.08M – 85.09M
-36.5% YoY
|
86.67M
81.99M – 91.64M
+3.7% YoY
|
89.80M
89.80M – 89.80M
+3.6% YoY
|
| EPS |
0.02
est: 0.09 (-77.7%)
|
0.09
est: 0.09 (-0.8%)
|
0.12
est: 0.11 (+9.5%)
|
0.13
est: 0.12 (+9.3%)
|
0.07
est: 0.09 (-23.5%)
|
0.06
est: 0.08 (-26.0%)
|
0.05
est: 0.05 (-2.4%)
|
0.07
est: 0.06 (+8.3%)
|
0.05
est: 0.06 (-19.5%)
|
0.06
est: 0.07 (-14.9%)
|
-0.02
est: 0.07 (-122.6%)
|
0.06
est: 0.07 (-11.4%)
|
0.05
0.05 – 0.05
-33.1% YoY
|
0.05
0.04 – 0.06
+10.5% YoY
|
0.06
0.05 – 0.06
+10.8% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-28 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-27 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-26 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-25 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-22 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-21 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-20 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-19 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-18 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-15 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-14 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-13 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-12 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-01 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
68.40M
OE per share TTM
0.18
Owner's Yield
24.72%
Maintenance CapEx ratio
64.08%
Maint CapEx / Avg PPE
44.4%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 6 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P International Small Cap ETF GWX | 0.02% | 181.9K | 0.40% |
| 2 | Dimensional - International Small Cap Value ETF DISV | 0.01% | 427.3K | 0.42% |
| 3 | Dimensional - International Small Cap ETF DFIS | 0.00% | 127.2K | 0.39% |
| 4 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 92.4K | 0.28% |
| 5 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 19.2K | 0.22% |
| 6 | Dimensional - International Core Equity Market ETF DFAI | 0.00% | — | 0.18% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
44.3K
Shares Outstanding
389.63M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Rebecca Redden | Chief Operating Officer | 547.1K | female |
| Richard Charles Henshaw | Executive Director | 385.5K | — |
| Peggy North | Chief Corporate Shared Services Officer | — | female |
| Rebecca Dean | Company Secretary and General Counsel | — | female |
| Tedd Fuell | Chief Governance & Risk Officer | — | female |
| Thierry Panthier | Chief Information Officer | — | male |
| Birol Akdogan | Interim Chief Financial Officer | — | male |
| Victoria Atkinson Afracma Fracs Mbbs | MD, CEO & Director | — | — |
| Deirdre Zander-Fox of | Chief Scientific Officer | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MVF.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
